Abstract: A composition formulated to improve the delivery of supplemental urolithin is provided. More particularly, the composition may be configured to improve the delivery of orally consumed supplemental urolithin. The composition comprises supplemental urolithin and a liposomal blend configured to encapsulate the supplemental urolithin. It is contemplated that encapsulating the supplemental urolithin with the liposomal blend improves the bioavailability of the supplemental urolithin by protecting the supplemental urolithin from degradation caused by the body's digestive system. The liposomal blend may be further operative to increase penetration of the supplemental urolithin in the bloodstream by binding to the user's small intestine, permitting the supplemental urolithin to pass directly into the user's bloodstream, where the supplemental urolithin can be delivered to the user's muscles and other desired regions of the body.

Abstract: A composition configured for oral consumption and formulated to improve the delivery of supplemental creatine is provided. The composition comprises supplemental creatine and a liposomal blend configured to encapsulate the supplemental creatine. Encapsulating the supplemental creatine with the liposomal blend improves the bioavailability of the supplemental creatine by protecting the supplemental creatine from degradation caused by the user's digestive system. The liposomal blend may further bind to the user's small intestine permitting the supplemental creatine to pass directly into the user's bloodstream, where it is accessible to the user's muscles.